Category Biology/Biotechnology

Common Therapeutic Target for IBD Rx may Protect against Intestinal Inflammation by Inhibiting Pathogenic T-cells

Intracellular tumour necrosis factor receptor-2 (TNFR2) signalling. Binding of tumour necrosis factor (TNF) to TNFR2 results in activation and recruitment of intracellular adaptor proteins that induce signal transduction promoting cell proliferation and survival via phosphorylation of endothelial/epithelial nonreceptor tyrosine kinase (Etkp40), which in turn transactivates vascular endothelial growth factor receptor-2 (VEGFR2p1054–1059), leading to phosphatidylinositol 3-kinase (PI3K)-Akt/PKB pathway.

Intracellular tumour necrosis factor receptor-2 (TNFR2) signalling. Binding of tumour necrosis factor (TNF) to TNFR2 results in activation and recruitment of intracellular adaptor proteins that induce signal transduction promoting cell proliferation and survival via phosphorylation of endothelial/epithelial nonreceptor tyrosine kinase (Etkp40), which in turn transactivates vascular endothelial growth factor receptor-2 (VEGFR2p1054–1059), leading to phosphatidylinositol 3-kinase (PI3K)-Akt/PKB pathway.

This discovery could lead to new treatment options for the 65% of individuals with IBD who do not respond or become resistant to anti-TNF medications...

Read More

Dried plums can reduce risk of colon cancer, research shows

Dr. Nancy Turner directed the lab team doing the research on health benefits of dried plums. (Texas A&M AgriLife Research photo)

Dr. Turner’s lab team, most of who are shown here, were instrumental in the research relating to the health benefits of dried plums. (Texas A&M AgriLife Research photo)

A diet containing dried plums can positively affect microbiota, also referred to as gut bacteria, throughout the colon, helping reduce the risk of colon cancer, researchers report. According to the American Cancer Society, colon cancer is the third leading cause of cancer-related deaths in the U.S. when men and women are considered separately, and the second-leading cause when the figures are combined. During 2015, colon cancer is expected to cause about 49,700 deaths nationwide.

“Our research explored the potential cancer-protective properties of dried plums using a well-established rat model of colon cancer,” she sai...

Read More

A different CRISPR Editing System for Simpler, More precise Genome Engineering: Cpf1

 

“This has dramatic potential to advance genetic engineering,” said Eric Lander, Director of the Broad Institute and one of the principal leaders of the human genome project. “The paper not only reveals the function of a previously uncharacterized CRISPR system, but also shows that Cpf1 can be harnessed for human genome editing and has remarkable and powerful features. The Cpf1 system represents a new generation of genome editing technology.”

In the new study, Zhang et al searched through hundreds of CRISPR systems in different types of bacteria, searching for enzymes with useful properties that could be engineered for use in human cells...

Read More

Cheaper Taxol Anti-Cancer drugs may stem from a Microbial ‘Bandage’ that protects Yew Trees from Fungi

Highlights •The cancer drug Taxol is a fungicide against wood-decaying fungi (WDF) in yew trees •Inside yew, a fungal endophyte produces Taxol and migrates to pathogen entry points •The endophyte sequesters Taxol in hydrophobic bodies (HBs); WDF induce their release •The HBs can coalesce to form extracellular barriers laced with fungicidal Taxol

Highlights •The cancer drug Taxol is a fungicide against wood-decaying fungi (WDF) in yew trees •Inside yew, a fungal endophyte produces Taxol and migrates to pathogen entry points •The endophyte sequesters Taxol in hydrophobic bodies (HBs); WDF induce their release •The HBs can coalesce to form extracellular barriers laced with fungicidal Taxol

The researchers found naturally occurring fungi in the yew’s vascular system act like an immune system to swarm a wound site and protect against invading pathogens. Taxol is harvested from yew bark for use as an important cancer-fighting drug, but efforts to make synthetic taxol in the lab have been unsuccessful.

Raizada said the findings might point drug makers to a less expensive synthetic process for making more of the substance...

Read More